CytoSorbents Corporation (CTSO)

[biotech48]

You preach the large scale well designed trial over and over.I am here to partially refute that. Yes, in an ideal world that is what the company would do. However, it has limited resources and Dr. Chan has done a great job of limiting dilution, there are only 30 million shares, which is almost unheard of. The company is marshaling it's resources for the REFRESH 2 trial which will open the door to sales in the US. Meanwhile, China can approve the use of Cytosorb, at no cost to the company, to treat a potential epidemic. You criticize the shotgun approach but multiple indications are being added at absolutely no cost to the company and others like CAR T cell will follow.